Metabolic plasticity for isoprenoid biosynthesis in bacteria
- 25 April 2013
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 452 (1) , 19-25
Abstract
Isoprenoids are a large family of compounds synthesized by all free-living organisms. In most bacteria, the common precursors of all isoprenoids are produced by the MEP (methylerythritol 4-phosphate) pathway. The MEP pathway is absent from archaea, fungi and animals (including humans), which synthesize their isoprenoid precursors using the completely unrelated MVA (mevalonate) pathway. Because the MEP pathway is essential in most bacterial pathogens (as well as in the malaria parasites), it has been proposed as a promising new target for the development of novel anti-infective agents. However, bacteria show a remarkable plasticity for isoprenoid biosynthesis that should be taken into account when targeting this metabolic pathway for the development of new antibiotics. For example, a few bacteria use the MVA pathway instead of the MEP pathway, whereas others possess the two full pathways, and some parasitic strains lack both the MVA and the MEP pathways (probably because they obtain their isoprenoids from host cells). Moreover, alternative enzymes and metabolic intermediates to those of the canonical MVA or MEP pathways exist in some organisms. Recent work has also shown that resistance to a block of the first steps of the MEP pathway can easily be developed because several enzymes unrelated to isoprenoid biosynthesis can produce pathway intermediates upon spontaneous mutations. In the present review, we discuss the major advances in our knowledge of the biochemical toolbox exploited by bacteria to synthesize the universal precursors for their essential isoprenoids.Keywords
This publication has 69 references indexed in Scilit:
- A RubisCO-like protein links SAM metabolism with isoprenoid biosynthesisNature Chemical Biology, 2012
- Crystal Structure of Brucella abortus Deoxyxylulose-5-phosphate Reductoisomerase-like (DRL) Enzyme Involved in Isoprenoid BiosynthesisJournal of Biological Chemistry, 2012
- Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycanNature Genetics, 2012
- ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndromeNature Genetics, 2012
- A Second Target of the Antimalarial and Antibacterial Agent Fosmidomycin Revealed by Cellular Metabolic ProfilingBiochemistry, 2011
- A new family of enzymes catalyzing the first committed step of the methylerythritol 4-phosphate (MEP) pathway for isoprenoid biosynthesis in bacteriaProceedings of the National Academy of Sciences, 2010
- Type II Isopentenyl Diphosphate Isomerase: Probing the Mechanism with Alkyne/Allene Diphosphate Substrate AnaloguesBiochemistry, 2010
- X-ray Structures of Isopentenyl Phosphate KinaseACS Chemical Biology, 2010
- A Secondary Kinetic Isotope Effect Study of the 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase-Catalyzed Reaction: Evidence for a Retroaldol-Aldol RearrangementJournal of the American Chemical Society, 2009
- The plastidial MEP pathway: unified nomenclature and resourcesTrends in Plant Science, 2008